Treatment With Intent to Generate Endovascular Reperfusion

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT03474549

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Rapid Medical (from the registry)
Registry
  • NCT NCT03474549
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Israel (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03474549. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-09 (actual); primary completion 2020-04-15 (actual). Results posted on 2024-05-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment With Intent to Generate Endovascular Reperfusion
Acronym
TIGER
Intervention (Device)
Tigertriever revascularization device
Lead sponsor
Rapid Medical (class: industry)

Record details

Record id
cardio:ct-nct03474549
Content hash
343959a94da3771396031acae861bc8544f8be532df322be034fc835259a73eb